Park, K.;                     Kim, Y.;                     Son, M.;                     Chae, D.;                     Park, K.    
        A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer. Pharmaceutics 2022, 14, 914.
    https://doi.org/10.3390/pharmaceutics14050914
    AMA Style
    
                                Park K,                                 Kim Y,                                 Son M,                                 Chae D,                                 Park K.        
                A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer. Pharmaceutics. 2022; 14(5):914.
        https://doi.org/10.3390/pharmaceutics14050914
    
    Chicago/Turabian Style
    
                                Park, Kyemyung,                                 Yukyung Kim,                                 Mijeong Son,                                 Dongwoo Chae,                                 and Kyungsoo Park.        
                2022. "A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer" Pharmaceutics 14, no. 5: 914.
        https://doi.org/10.3390/pharmaceutics14050914
    
    APA Style
    
                                Park, K.,                                 Kim, Y.,                                 Son, M.,                                 Chae, D.,                                 & Park, K.        
        
        (2022). A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer. Pharmaceutics, 14(5), 914.
        https://doi.org/10.3390/pharmaceutics14050914